Does acute rhinosinusitis require antibiotic therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does a Sinus Infection Need Antibiotics?

Most sinus infections do not need antibiotics because 98–99.5% are viral and resolve spontaneously within 7–10 days without treatment. 1, 2

When Antibiotics Are NOT Indicated

  • Do not prescribe antibiotics for symptoms lasting less than 10 days unless severe features are present (fever ≥39°C with purulent discharge for ≥3 consecutive days). 1, 2
  • Purulent nasal discharge alone does not indicate bacterial infection—it reflects normal neutrophil activity in viral inflammation and should not trigger antibiotic therapy. 3
  • The presence of rhinorrhea, cough, oral ulcers, and/or hoarseness strongly suggests viral etiology and argues against bacterial infection. 3

Three Clinical Patterns That Justify Antibiotics

Antibiotics should be prescribed only when acute bacterial rhinosinusitis (ABRS) is confirmed by at least one of these patterns: 1, 2

  1. Persistent symptoms ≥10 days without improvement: purulent nasal discharge plus either nasal obstruction or facial pain/pressure/fullness 1, 2

  2. Severe symptoms ≥3–4 consecutive days: fever ≥39°C with purulent nasal discharge and facial pain 1, 2

  3. "Double sickening": initial improvement from a viral URI followed by new-onset fever, worsening nasal discharge, or markedly increased cough within 10 days 1, 2

First-Line Antibiotic Regimen

When antibiotics are indicated, amoxicillin-clavulanate 875 mg/125 mg twice daily for 5–10 days is the preferred first-line agent, providing 90–92% predicted clinical efficacy against the three major pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis). 2

Why Amoxicillin-Clavulanate Over Plain Amoxicillin

  • The clavulanate component is essential because 30–40% of H. influenzae and 90–100% of M. catarrhalis produce β-lactamase enzymes that inactivate plain amoxicillin. 2
  • Plain amoxicillin may be used only for mild disease in patients who have not received antibiotics in the preceding 4–6 weeks. 2

Watchful Waiting Strategy

For patients meeting the persistent-symptom criterion (≥10 days), initial observation without antibiotics is appropriate when reliable follow-up can be ensured. 2, 4

  • Start antibiotics only if there is no improvement by day 7 or if symptoms worsen at any time. 2
  • The number needed to treat (NNT) with antibiotics is 10–15 to achieve one additional cure compared with placebo, reflecting the high rate of spontaneous recovery. 2

Essential Adjunctive Therapies (For All Patients)

These should be added regardless of whether antibiotics are prescribed: 2, 5

  • Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution—supported by strong evidence from multiple randomized controlled trials. 2
  • Saline nasal irrigation 2–3 times daily provides symptomatic relief and aids mucus clearance. 2, 5
  • Analgesics (acetaminophen or ibuprofen) for pain and fever control. 2, 3

Monitoring and Reassessment

  • Reassess at 3–5 days of antibiotic therapy: if no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch to high-dose amoxicillin-clavulanate (2 g/125 mg twice daily) or a respiratory fluoroquinolone (levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily). 2
  • Reassess at 7 days: persistent or worsening symptoms warrant confirmation of diagnosis, exclusion of complications (orbital cellulitis, meningitis, intracranial abscess), and consideration of imaging or ENT referral. 2

Alternatives for Penicillin Allergy

Non-Severe (Non-Type I) Penicillin Allergy

  • Second- or third-generation cephalosporins (cefuroxime-axetil, cefpodoxime-proxetil, cefdinir, or cefprozil) for 10 days—cross-reactivity with penicillins is negligible (<1%). 2

Severe (Type I/Anaphylactic) Penicillin Allergy

  • Respiratory fluoroquinolones are preferred: levofloxacin 500 mg once daily for 10–14 days or moxifloxacin 400 mg once daily for 10 days, both achieving 90–92% predicted efficacy against multidrug-resistant pathogens. 2

Common Pitfalls to Avoid

  • Do not obtain routine imaging (X-ray or CT) for uncomplicated acute rhinosinusitis; up to 87% of viral upper-respiratory infections show sinus abnormalities on imaging, leading to unnecessary interventions. 2
  • Avoid macrolides (azithromycin, clarithromycin) due to 20–25% resistance rates in S. pneumoniae and H. influenzae. 2
  • Avoid trimethoprim-sulfamethoxazole due to ≈50% resistance in S. pneumoniae and ≈27% in H. influenzae. 2
  • Ensure adequate treatment duration (≥5 days for adults) to prevent relapse. 2

Red-Flag Situations Requiring Urgent ENT Referral

  • No improvement after 7 days of appropriate second-line antibiotic therapy 2
  • Worsening symptoms at any point (increasing facial pain, fever, purulent drainage) 2
  • Signs of complications: severe headache, visual changes, periorbital swelling/erythema, proptosis, diplopia, altered mental status, or cranial nerve deficits 2
  • Recurrent sinusitis (≥3 episodes per year) suggesting underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Acute Nasopharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Rhinitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.